Amarin Corporation plc.
Edit Page
Report
Scan day: 05 February 2014 UTC
8
Virus safety - good
Description: A neuroscience company focused on the research, development and commercialisation of novel drugs for the treatment of central nervous system ("CNS") disorders.
Amarin, Omega-3, hypertriglyceridemia, cardiovascular, AMR101, ultra pure EPA, lipid science - Amarin Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Vascepa® (icosapent ethyl) is Amarin's first FDA approved product and is available in the United States by prescription. For more information about Vascepa visit
Size: 587 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Amarin, Omega-3, hypertriglyceridemia, cardiovascular, AMR101, ultra pure EPA, lipid science - Amarin |
| Keywords: | Amarin, cardiovascular, Omega-3, hypertriglyceridemia, dyslipidemia, lipid science, research, development, drugs, central nervous system, Miraxion, Declan Doogan, Stuart Sedlack, Paresh Sonin, Jonathan Rowe AMR101, myasthenia gravis, EN101, cardiovascular, triglyceride lowering, lipid, EPA, eicosapentaenoic acid, ethyl-EPA, |
| Description: | Amarin is a clinical stage biopharmaceutical company with a lead program in Phase 3 for hypertriglyceridemia. |
| IP-address: | 184.168.193.41 |
WHOIS Info
| NS | Name Server: NS01.DOMAINCONTROL.COM Name Server: NS02.DOMAINCONTROL.COM |
| WHOIS | Status: clientDeleteProhibited Status: clientRenewProhibited Status: clientTransferProhibited Status: clientUpdateProhibited |
| Date | Creation Date: 06-jan-2002 Expiration Date: 06-jan-2015 |